Brean Capital Positive On Zogenix, Says Favorable Phase 3 Of Cannabidiol Is Positive For ZX008, Sees Potential For Study 504 Read-Out To Yield Support For Premium Pricing & Exclusivity In EU, Maintains Buy And $28 PT